American Society of Clinical Oncology

SHERPA: White

People

  1. Solit
    Solit
  2. Berger
    Berger
  3. Iyer
    Iyer
  4. Schultz
    Schultz
  5. Al-Ahmadie
    Al-Ahmadie
  6. Bajorin
    Bajorin
  7. Arcila
    Arcila
  8. Rosenberg
    Rosenberg
  9. Bochner
    Bochner
  10. Ladanyi
    Ladanyi

Groups

  1. Department of Medicine (181)
  2. GSK Faculty (181)
  3. Genitourinary Oncology Service (181)
  4. Human Oncology and Pathogenesis Program (181)
  5. Solid Tumor Oncology Division (181)
  6. Department of Pathology and Laboratory Medicine (140)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (122)
  8. Epidemiology and Biostatistics (88)
  9. Surgery (83)
  10. Hematology-Oncology Fellows (75)
Search Within
  1. "David Solit"
Formats
  1. Meeting Abstract (141)
  2. Journal Article (40)
Groups
  1. Department of Medicine (181)
  2. GSK Faculty (181)
  3. Genitourinary Oncology Service (181)
  4. Human Oncology and Pathogenesis Program (181)
  5. Solid Tumor Oncology Division (181)
  6. Department of Pathology and Laboratory Medicine (140)

More Groups

People
  1. David Solit (181)
  2. Michael Berger (105)
  3. Gopakumar Iyer (54)
  4. Nikolaus Schultz (50)
  5. Hikmat Al-Ahmadie (48)
  6. Dean Bajorin (44)

More People

Years
  1. 2025 (3)
  2. 2024 (10)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (12)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. JCO Precision Oncology (17)
  3. JCO Clinical Cancer Informatics (1)

Results (181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical utility and prognostic implications of circulating cell-free DNA in biliary tract cancer
    Journal Article

    Cowzer, D.; Darmofal, M.; Seier, K.; Thummalapalli, R.; Walch, H.; El Dika, I.; Khalil, D. N.; Park, W.; Dhyani, A.; Yaqubie, A.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Optimizing mainstreaming of genetic testing in parallel with ovarian and endometrial cancer tumor testing: How do we maximize our impact?
    Journal Article

    Liu, Y. L.; Sia, T. Y.; Varice, N.; Wu, M.; Byrne, M.; Khurram, A.; Kemel, Y.; Sheehan, M.; Galle, J.; Sabbatini, P.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • HER2 and PD-L1 immunohistochemistry (IHC) expression, and HER2 genomic alterations: Associations and clinical outcomes for advanced bladder cancer
    Meeting Abstract

    Aggen, D. H.; Shah, N. J.; Zheng, J.; Alam, S. M.; Balar, O.; Niederhausern, A.; Regazzi, A. M.; Ratna, N.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes
    Meeting Abstract

    Shah, N. J.; Aggen, D. H.; Zheng, J.; Niederhausern, A.; Alam, S. M.; Balar, O.; Bahadur, N.; Watson, A.; Regazzi, A. M.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma
    Meeting Abstract

    Alam, S. M.; Teo, M. Y.; Woo, J.; Sarfaty, M.; Funt, S. A.; Aggen, D. H.; Lee, C. H.; Carlo, M. I.; Gandhi, J.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape
    Meeting Abstract

    Shamseddine, A.; Abbas, N.; Chatila, W. K.; Walch, H. S.; Eichholz, J.; Schultz, N.; Solit, D. B.; Charafeddine, M.; Al Darazi, M.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and genomic analysis of HER2-mutant, metastatic triple-negative breast cancer treated with neratinib alone or in combination with trastuzumab in the phase 2 SUMMIT basket trial
    Meeting Abstract

    Jhaveri, K. L.; Hurvitz, S. A.; Brufsky, A.; Bose, R.; de Miguel, M. J.; Evron, E.; Unni, N.; Reid, S. A.; Quinn, D. I.; Mahalingam, D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save